CRISPR Therapeutics AG - Common Shares (CRSP) stock analysis

CRSP · CRISPR Therapeutics AG - Common Shares

Latest recorded price: USD 40.37

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 43.1%, free cash flow margin -9,855.5%, ROIC -222.3%. The model flags 2 risk signals for this company (2 high severity).

Similar companies in Healthcare